ATC code J04
ATC code J04 Antimycobacterials is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup J04 is part of the anatomical group J Antiinfectives for systemic use.[4]
| ATC codes |
|---|
| J Antiinfectives for systemic use |
| J01 Antibacterials for systemic use |
| J02 Antimycotics for systemic use |
| J04 Antimycobacterials |
| J05 Antivirals for systemic use |
| Human only |
| J06 Immune sera and immunoglobulins |
| J07 Vaccines |
| ATCvet only |
| QJ51 Antibacterials for intramammary use |
| QJ54 Antimycobacterials for intramammary use |
|
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QJ04.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
J04A Drugs for treatment of tuberculosis
J04AA Aminosalicylic acid and derivatives
- J04AA01 Aminosalicylic acid
- J04AA02 Sodium aminosalicylate
- J04AA03 Calcium aminosalicylate
J04AB Antibiotics
- J04AB01 Cycloserine
- J04AB02 Rifampicin
- J04AB03 Rifamycin
- J04AB04 Rifabutin
- J04AB05 Rifapentin
- J04AB06 Enviomycin
- J04AB30 Capreomycin
J04AC Hydrazides
- J04AC01 Isoniazid
- J04AC51 Isoniazid, combinations
J04AD Thiocarbamide derivatives
- J04AD01 Protionamide
- J04AD02 Tiocarlide
- J04AD03 Ethionamide
J04AK Other drugs for treatment of tuberculosis
- J04AK01 Pyrazinamide
- J04AK02 Ethambutol
- J04AK03 Terizidone
- J04AK04 Morinamide
- J04AK05 Bedaquiline
- J04AK06 Delamanid
- J04AK07 Amithiozone
- J04AK08 Pretomanid
J04AM Combinations of drugs for treatment of tuberculosis
- J04AM01 Streptomycin and isoniazid
- J04AM02 Rifampicin and isoniazid
- J04AM03 Ethambutol and isoniazid
- J04AM04 Thioacetazone and isoniazid
- J04AM05 Rifampicin, pyrazinamide and isoniazid
- J04AM06 Rifampicin, pyrazinamide, ethambutol and isoniazid
- J04AM07 Rifampicin, ethambutol and isoniazid
- J04AM08 Isoniazid, sulfamethoxazole, trimethoprim and pyridoxine
J04B Drugs for treatment of lepra
J04BA Drugs for treatment of lepra
- J04BA01 Clofazimine
- J04BA02 Dapsone
- J04BA03 Aldesulfone sodium
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code J04". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QJ04". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.